Milroy disease and the VEGFR-3 mutation phenotype
- PMID: 15689446
- PMCID: PMC1735984
- DOI: 10.1136/jmg.2004.024802
Milroy disease and the VEGFR-3 mutation phenotype
Abstract
Primary congenital lymphoedema (Milroy disease) is a rare autosomal dominant condition for which a major causative gene defect has recently been determined. Mutations in the vascular endothelial growth factor receptor 3 (VEGFR-3) gene have now been described in 13 families world-wide. This is a review of the condition based on the clinical findings in 71 subjects from 10 families. All 71 individuals have a mutation in VEGFR-3. Ninety per cent of the 71 individuals carrying a VEGFR-3 mutation showed signs of oedema, which was confined in all cases to the lower limbs. In all but two cases onset of swelling was from birth. Other symptoms and signs included cellulitis (20%), large calibre leg veins (23%), papillomatosis (10%), and upslanting toenails (10%). In males, hydrocoele was the next most common finding after oedema (37%). Thorough clinical examination of these patients indicates that there are few clinical signs in addition to lower limb oedema. Rigorous phenotyping of patients produces a high yield of VEGFR-3 mutations.
Similar articles
-
Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.Hum Genet. 2009 Jan;124(6):625-31. doi: 10.1007/s00439-008-0586-5. Epub 2008 Nov 12. Hum Genet. 2009. PMID: 19002718
-
Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.Circ Res. 2013 Mar 15;112(6):956-60. doi: 10.1161/CIRCRESAHA.113.300350. Epub 2013 Feb 14. Circ Res. 2013. PMID: 23410910
-
A novel VEGFR3 mutation causes Milroy disease.Am J Med Genet A. 2007 Jun 1;143A(11):1212-7. doi: 10.1002/ajmg.a.31703. Am J Med Genet A. 2007. PMID: 17458866
-
Milroy's primary congenital lymphedema in a male infant and review of the literature.In Vivo. 2010 May-Jun;24(3):309-14. In Vivo. 2010. PMID: 20555004 Review.
-
FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update.Hum Mutat. 2013 Jan;34(1):23-31. doi: 10.1002/humu.22223. Epub 2012 Oct 16. Hum Mutat. 2013. PMID: 23074044 Review.
Cited by
-
Aberrant lymphatic endothelial progenitors in lymphatic malformation development.PLoS One. 2015 Feb 26;10(2):e0117352. doi: 10.1371/journal.pone.0117352. eCollection 2015. PLoS One. 2015. PMID: 25719418 Free PMC article.
-
Clinical staging and genetic profiling of Korean patients with primary lymphedema using targeted gene sequencing.Sci Rep. 2022 Aug 10;12(1):13591. doi: 10.1038/s41598-022-17958-7. Sci Rep. 2022. PMID: 35948757 Free PMC article.
-
[Genetics, diagnostics and clinical presentation of primary lymphoedema].Dermatologie (Heidelb). 2023 Aug;74(8):594-604. doi: 10.1007/s00105-023-05183-w. Epub 2023 Jul 4. Dermatologie (Heidelb). 2023. PMID: 37402871 Review. German.
-
Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.J Hum Genet. 2006;51(10):846-850. doi: 10.1007/s10038-006-0031-3. Epub 2006 Aug 19. J Hum Genet. 2006. PMID: 16924388
-
New developments in clinical aspects of lymphatic disease.J Clin Invest. 2014 Mar;124(3):915-21. doi: 10.1172/JCI71608. Epub 2014 Mar 3. J Clin Invest. 2014. PMID: 24590276 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous